Washington Real Estate Investment Trust (NYSE: WRE | news | PowerRating | PR Charts ) operates as a real estate investment trust (REIT). The company engages in the ownership, operation, and development of real properties in Washington/Baltimore region. It owns a portfolio of office buildings, industrial/flex properties, multifamily buildings, and retail centers. As of February 12, 2007, Washington Real Estate Investment Trust owned a portfolio of 83 properties, consisting of 14 retail centers, 24 general purpose office properties, 13 medical office properties, 23 industrial/flex properties, and 9 multi-family properties. Washington Real Estate Investment Trust qualifies as a REIT for federal income tax purposes. As a REIT, it would not be taxed on the portion of its income, which is distributed to shareholders, provided it distributes at least 90% of its taxable income. The company was founded in 1960 and is headquartered in Rockville, Maryland. With 46.68 million shares outstanding and 5.84 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of WRE. According to quarterly data provided by the SEC, there were still 71,200 shares of WRE that were failing-to-deliver as of September 26, 2007.
Nuveen New Jersey Dividend Advantage Municipal Fund 2 (AMEX: NUJ) operates as closed-end management investment company. The fund primarily invests in a diversified portfolio of municipal obligations issued by state and local government authorities. Its investment portfolio includes investments in tax obligation/limited, U.S. guaranteed, transportation, education and civic, healthcare, tax obligation/general, consumer staples, water and sewer, utilities, and other sectors. Nuveen Asset Management serves as the investment advisor of the fund. The fund was formed in 1999 and is based in Chicago, Illinois. With 4.52 million shares outstanding and 1,800 shares declared short as of March 2008, there is no longer a failure to deliver in shares of NUJ.
Akeena Solar Inc. (NASDAQ: AKNS | news | PowerRating | PR Charts ) engages in the design, integration, installation, marketing, and sale of solar power systems for residential and small commercial customers in the United States. It focuses on the design and integration of grid-tied solar power systems, which are electrically connected to the utility grid so that excess energy produced during the day flows backwards through the utility's electric meter. The company serves commercial customers, including schools, and housing and owner occupied businesses consisting of wineries and small commercial offices, as well as residential customers, including high-income professionals. Akeena Solar, Inc. sells its products through print, Web, and radio advertisements, as well as through participation in industry trade shows, individual consultations with prospective customers, and sales force. The company was founded in 2001 and is headquartered in Los Gatos, California. With 27.89 million shares outstanding and 2.43 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of AKNS. According to quarterly data provided by the SEC, there were still 209,547 shares of AKNS that were failing-to-deliver as of September 28, 2007.
BioLase Technology Inc. (NASDAQ: BLTI | news | PowerRating | PR Charts ) a medical technology company, engages in the development, manufacture, and marketing of lasers and related products focused on technologies for applications and procedures in dentistry and medicine. Its principle products are dental laser systems that enable general dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications. It offers two categories of laser system products, including Waterlase family of products and Diolase family of products. The Waterlase system uses a patented combination of water and laser to perform dental procedures performed using dental drills, scalpels, and other dental instruments for cutting soft and hard tissue. Its Waterlase systems consist of Waterlase YSGG and Waterlase MD. The company's Diolase laser systems consist of the ezlase, DioLase Plus, and LaserSmile systems, which use semiconductor diode laser to perform soft tissue and cosmetic procedures, including tooth whitening. It also manufactures and sells disposable products and accessories for its laser systems. The company markets its laser systems through direct sales force and a network of independent distributors in the United States, Canada, Australia, New Zealand, Latin America, and various countries throughout Europe and the Pacific Rim. The company was founded in 1984 and is headquartered in Irvine, California. With 23.89 million shares outstanding and 2.33 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of BLTI. According to quarterly data provided by the SEC, there were still 37,607 shares of BLTI that were failing-to-deliver as of September 28, 2007.
Cytogen Corp. (NASDAQ: CYTO | news | PowerRating | PR Charts ) a biopharmaceutical company, builds, develops, and commercializes a portfolio of specialty pharmaceutical products for the treatment of cancer. It markets QUADRAMET (samarium Sm-153 lexidronam injection), PROSTASCINT (capromab pendetide), and SOLTAMOX (tamoxifen citrate) to the United States oncology market. QUADRAMET is approved for the treatment of pain in patients whose cancer has spread to the bone, PROSTASCINT is a prostate-specific membrane antigen (PSMA)-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer, and SOLTAMOX is the liquid hormonal therapy approved in the U.S. for the treatment of breast cancer in adjuvant and metastatic settings. The company also offers CAPHOSOL, an advanced electrolyte solution for the treatment of oral mucositis and dry mouth. CAPHOSOL is approved in the U.S. as a prescription medical device. It is also developing CYT-500, a third-generation radiolabeled antibody to treat prostate cancer. The company was founded in 1980. It was formerly known as Hybridex, Inc. and changed its name to Cytogen Corporation in the same year. Cytogen Corporation is based in Princeton, New Jersey. With 35.57 million shares outstanding and 45,900 shares declared short as of March 2008, there is no longer a failure to deliver in shares of CYTO. According to quarterly data provided by the SEC, there were still 241,031 shares of CYTO that were failing-to-deliver as of September 28, 2007.
China Finance Online Co. Ltd. (NASDAQ: JRJC | news | PowerRating | PR Charts ) through its subsidiaries, engages in selling online financial services analyzing financial and listed company information in the People's Republic of China. It offers subscription-based services based on a single information platform that integrates data and information from various sources with features and functions, such as data and information search, retrieval, delivery, storage, and analysis. The company delivers its features and functions using software tools, which include financial analysis tools that permit users to calculate and analyze quantitatively financial data; current and historical financial data and information for listed company stocks, bonds, and mutual funds; categorized news and research reports; and online forums and bulletin boards. China Finance provides its services to individual investors, institutional investors, high-net worth individuals, investment bankers, stock analysts, financial reporters, and middle class individuals. The company was founded in 1998 and is based in Beijing, the People's Republic of China. With 18.95 million shares outstanding and 3.86 million shares declared short as of March 2008, there is no longer a failure to deliver in shares of JRJC. According to quarterly data provided by the SEC, there were still 209,431 shares of JRJC that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 1,900,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
|
|
